Sexual Functioning After Erection Prosthesis Placement in Post Phalloplasty Transgender Persons
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital, Ghent
About this trial
This study aims to explore sexual satisfaction among transgender men and their partners following the placement of erectile prostheses after phalloplasty. While phalloplasty can create a neophallus, the lack of natural erectile tissue often necessitates the use of erectile aids, including internal prostheses. However, these prostheses, originally designed for cisgender men, face challenges when used in transgender patients, such as higher risks of complications, infections, and mechanical failures. Despite these issues, some studies report high patient satisfaction, though partner satisfaction rates are significantly lower. The study will use validated and non-validated questionnaires to assess satisfaction with various types of erectile prostheses, addressing the gap in understanding how these devices impact the sexual and relational functioning of both transgender men and their partners. These questionnaires will be provided to all included patients that are minimum 6 months after placement of an internal erection prosthesis and have a functional erection prosthesis in place
Eligibility criteria
Qualifiers
Patient and partner age ≥ 18 years.
Transgender or gender non-conforming individuals diagnosed according to the DSM-5 diagnostic criteria for gender dysphoria.
Patients have undergone phalloplasty as a form of genital gender affirming surgery (any type of flap combination or technique is allowed).
Erection prosthesis placement ≥ 6 months after phalloplasty, performed at the Ghent University Hospital. Any type of prosthesis is allowed.
Disqualifiers
Patient age < 18 years.
Cisgender patients treated with phalloplasty and/or erection prosthesis for various reasons.
The erection prosthesis has been explanted or the current prosthesis is nonfunctional at time of data assessment.
Erection prosthesis placement < 6 months before study start will be excluded.
Trial design
Treatments tested in this trial
- Questionnaire
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov